EAF1 is known to act as a transcriptional transactivator of ELL (Eleven-Nineteen Lysine-Rich Leukemia) and ELL2 elongation activities . It is involved in the regulation of transcription elongation from RNA polymerase II promoter . This protein is part of the transcription elongation factor complex and is located in the intercellular bridge and nuclear body .
EAF1 enhances the self-association of ELL, which reduces its interaction with other components of the Super Elongation Complex (SEC). This interaction is crucial for the regulation of transcription during genotoxic stress . EAF1 also plays a role in the inhibition of HIV-1 transcription through the inhibition of super elongation complex formation .
The recombinant form of EAF1 is used in various research applications to study its function and role in transcription regulation. It is also used to understand its interactions with other proteins and its impact on gene expression.